Remove keyword womens-health
article thumbnail

Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC)

Rethinking Clinical Trials

CVD is the leading cause of mortality in women. Hospital admissions with acute coronary syndrome in women younger than 55 years increased 21% in 1995-1999 and 31% in 2010-2014. The biggest barrier for CV medicine is the lack of women leaders in CV. years for males and 5.5 years for females at age 45 years or older.

article thumbnail

Grand Rounds October 21, 2022: Disinformation, Cyberthreat, and Choice: Protecting Patients and Clinical Research From the Digital Triple Threat (Eric Perakslis, PhD; Andrea Downing)

Rethinking Clinical Trials

Professor, Department of Population Health Sciences. Health care and the internet are intertwined. Perakslis said his definition of digital health is any time you mix medical information and the internet. There are doable ways to increase cybersecurity in health care. Duke Clinical Research Institute. Andrea Downing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds August 19, 2022: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield, MD, MPH; Michelle Kelsey, MD)

Rethinking Clinical Trials

Associate Professor, Global Health. We have seen that having a higher proportion of women authors resulted in a higher proportion of women enrolled per trial. Gerald Bloomfield, MD, MPH. Associate Professor with Tenure, Medicine. Duke University School of Medicine. Michelle Kelsey, MD. Assistant Professor of Medicine.

article thumbnail

Grand Rounds December 2, 2022: A Randomized Controlled Trial of Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned (G. Michael Felker, MD, MHS)

Rethinking Clinical Trials

This study asks how can we better facilitate health behaviors in patients with chronic diseases and can we leverage technology? The trial enrolled 187 patients, with 35% women, 47% African American, 10% Hispanic, age 59 years. Director, Cardiovascular and Metabolism Research, DCRI. Pragmatic Clinical Trials, Heart Failure, Diabetes.

Trials 130
article thumbnail

Stop Snoring Exercise Program cb vsl | Blue Heron Health News

The Pharma Data

Product Name: Stop Snoring Exercise Program cb vsl | Blue Heron Health News. Click here to get Stop Snoring Exercise Program cb vsl | Blue Heron Health News at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

article thumbnail

Products/Services/ClickBank E-Book | Alfred Health Care

The Pharma Data

Product Name: Products/Services/ClickBank E-Book | Alfred Health Care. Click here to get Products/Services/ClickBank E-Book | Alfred Health Care at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. it I am sure.